Kirsi Pylvänäinen

7PUBLICATIONS
87CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 13, 2025
NOUS-209 Off-the-shelf Immunotherapy Has the Potential to Hit Primary and Metachronous Colorectal and Urothelial Cancers in Lynch Syndrome.

Lorenzo De Marco, Elisa Micarelli, Joni Panula

|Mar 29, 2024
Circulating miRNA Signature Predicts Cancer Incidence in Lynch Syndrome-A Pilot Study.

Tero Sievänen, Tiina Jokela, Matti Hyvärinen

|Mar 06, 2023
Tumor-independent Detection of Inherited Mismatch Repair Deficiency for the Diagnosis of Lynch Syndrome with High Specificity and Sensitivity.

Minttu Kansikas, Laura Vähätalo, Jukka Kantelinen

|Jul 25, 2022
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.

John C Mathers, Faye Elliott, Finlay Macrae

|Mar 10, 2022
Testing for Lynch Syndrome in Endometrial Carcinoma: From Universal to Age-Selective MLH1 Methylation Analysis.

Annukka Pasanen, Mikko Loukovaara, Elina Kaikkonen

|Jul 02, 2021
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study.

Mev Dominguez-Valentin, John-Paul Plazzer, Julian R Sampson

Pageof 2

Frequent Collaborators

6 joint publications

Toni T Seppälä

4 joint publications

Jukka-Pekka Mecklin

2 joint publications

Tero Sievänen

2 joint publications

Eija K Laakkonen